Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 9/20 | 0.48 |
| ▸ | MC5R | P33032 | 9/20 | 0.48 |
| ▸ | MC3R | P41968 | 9/20 | 0.48 |
| ▸ | MC1R | Q01726 | 9/20 | 0.48 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.48 |
| ▸ | ITGB3 | P05106 | 10/20 | 0.47 |
| ▸ | ITGAV | P06756 | 6/20 | 0.47 |
| ▸ | ITGB5 | P18084 | 3/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.47 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.47 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8207851 | 1.00 | MC4R (0.48) | MC4RMC5RMC3RMC1RCXCR4 | |
| SCHEMBL29568895 | 0.94 | ITGB3 (0.51) | MC4RMC5RMC3RMC1RCXCR4 | |
| SCHEMBL18968797 | 0.94 | ITGB3 (0.51) | MC4RMC5RMC3RMC1RCXCR4 | |
| SCHEMBL29569086 | 0.92 | ITGB3 (0.49) | MC4RMC5RMC3RMC1RCXCR4 | |
| SCHEMBL24975089 | 0.91 | ITGB3 (0.54) | MC4RMC5RMC3RMC1RITGB3 | |
| SCHEMBL30121071 | 0.91 | ITGB3 (0.50) | MC4RMC5RMC3RMC1RCXCR4 | |
| SCHEMBL20888358 | 0.91 | ITGB3 (0.58) | MC4RMC5RMC3RMC1RITGB3 | |
| SCHEMBL21766911 | 0.91 | ITGB3 (0.58) | MC4RMC5RMC3RMC1RITGB3 | |
| SCHEMBL30121037 | 0.91 | ITGB3 (0.50) | MC4RMC5RMC3RMC1RCXCR4 | |
| SCHEMBL19605458 | 0.91 | ITGB3 (0.58) | MC4RMC5RMC3RMC1RITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024092256-A2 | PEPTIDE-ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2024-05-02 | — | — | WO | disclosed |